Fatty Liver Disease

An Open Labelled RCT Study To Assess The Cobined Effect Of Virechanottara Yakrutshoolvinashini Vati With Phalatrikadi Kashaya Over Sharapunkha Kshara With Sharapunkha Kashaya In Fatty Liver Disease (Yakrutgatamedoroga) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073600

Enrollment

Registered

2024-09-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E888- Other specified metabolic disorders

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: subjects with signs and symptoms of fatty liver disease USG evidence of fatty liver grade 1 to 3 irrespective of cause who sings for informed consent patients fit for virechana karma and kshara intake

Exclusion criteria

Exclusion criteria: subject suffering with multiorgan failure sepsis and shock which interfere with the treatment will be excluded pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
correction in USG Fatty Liver grading from 3to2 2to1 1to normalTimepoint: 6 weeks 3 days	—

Secondary

Measure	Time frame
prevention from complications like cirrhosis and HCCTimepoint: 6 weeks 3 days	—

Countries

India

Contacts

Public ContactDr Ashish Kumar Khatik

Taranath Government Ayurveda Medical college and hospital, Ballary

ramshugar22@gmail.com8971311520

Outcome results